-
required. Preferred Qualifications Ph.D. in immunology, genetic engineering or related fields. Great fund of knowledge of tumor immunology principles. Able to assess scRNAseq datasets and highly parametric
-
of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic Center for Infectious Disease (GCID) established by
-
of neurodevelopmental and neuropsychiatric conditions using cutting-edge proximity proteomics, protein engineering, CRISPR genome engineering, computational structural biology, and high-throughput electrophysiological
-
engineered mouse models (GEMMs). We are actively seeking a highly motivated Postdoctoral Associate who shares our passion for translational tumor research. For further insight into our work, please consider
-
cancer and their survival, development of improved technology to identity extracellular platelet phosphatase in the tumor microenvironment and large-scale analysis and validation of platelet phosphatase in
-
the immune response to lung cancer and their survival, development of improved technology to identity extracellular platelet phosphatase in the tumor microenvironment and large-scale analysis and validation
-
, genetic engineering, murine modeling of cancer. Uses computer-interfaced equipment, robotics, and/or high-technology applications to perform work duties. Prepares and gives impressive seminar talks as
-
cell-based assays, genetic engineering, murine modeling of cancer. Uses computer-interfaced equipment, robotics, and/or high-technology applications to perform work duties. Prepares and gives impressive
-
Qualifications PhD in neuroscience, experimental psychology, engineering, computer science, physics, or related field. The candidate should have experience with collecting and processing biological signals (M/EEG
-
of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic Center for Infectious Disease (GCID) established by